Form D — Auron Therapeutics, Inc.
0001746139-25-000003 · filed 2025-12-23
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $42,289,180
- Total sold
- $27,289,180
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Auron Therapeutics, Inc.
- CIK
- 1746139
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 55 CHAPEL STREET
NEWTON, MA 02458 - Phone
- 310-922-5881
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Katharine Yen · Executive OfficerNewton, MA Find on LinkedIn ↗
-
Alexandra Cantley · DirectorNewton, MA Find on LinkedIn ↗
-
Briggs Duncan Morrison · DirectorNewton, MA Find on LinkedIn ↗
-
Anna French · DirectorNewton, MA Find on LinkedIn ↗
-
Pini Orbach · DirectorNewton, MA Find on LinkedIn ↗
-
Serge Messerlian · DirectorNewton, MA Find on LinkedIn ↗
-
Victoria Richon · DirectorNewton, MA Find on LinkedIn ↗
View original on SEC EDGAR.